Triphala Ameliorates Nephropathy via Inhibition of TGF-β1 and Oxidative Stress in Diabetic Rats

被引:21
|
作者
Suryavanshi, Sachin, V [1 ]
Garud, Mayuresh S. [1 ]
Barve, Kalyani [1 ]
Addepalli, Veeranjaneyulu [1 ]
Utpat, Sachin, V [2 ]
Kulkarni, Yogesh A. [1 ]
机构
[1] SVKMs NMIMS, Shobhaben Pratapbhai Patel Sch Pharm & Technol Ma, VL Mehta Rd, Mumbai 400056, Maharashtra, India
[2] MES Ayurveda Mahavidyalaya, Tal Khed, Ratnagiri, India
关键词
Diabetic nephropathy; Triphala churna; Emblica officinalis; Terminalia belerica; Terminalia chebula; Diabetic complications; RENAL DAMAGE; COMPLICATIONS; APOPTOSIS;
D O I
10.1159/000508238
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: Advanced glycation end products, oxidative stress, and TGF-beta expression play a crucial role in pathophysiology of diabetic nephropathy. Inhibition of oxidative stress and TGF-beta expression by natural traditional medicines may give an economic and safe alternative treatment option. Triphala churna, a traditional medicine, has been proved to have potent antioxidant activity, and individual components of it have shown significant antidiabetic activity. Hence, the present study was designed to study the effect of Triphala churna in diabetic nephropathy in rats. Methods: Diabetes was induced in rats by administration of streptozotocin (55 mg/kg i.p.). Four weeks after induction of diabetes, the animals were treated with Triphala churna at the doses of 250, 500, and 1,000 mg/kg for next 4 weeks. Various biochemical and urine parameters such as glucose, creatinine, blood urea nitrogen (BUN), total protein, and albumin were assessed at the end of study. Creatinine clearance, BUN clearance, and glomerular filtration rate were determined. Oxidative stress parameters such as malondialdehyde, catalase, reduced glutathione, and superoxide dismutase were determined in kidney tissues. TGF-beta 1 expression was measured with ELISA, immunohistochemistry, and western blot techniques. Histopathology study was carried out with haemotoxylin and eosin, periodic acid-Schiff, and Masson's trichrome staining to determine histological changes. Results: Treatment with Triphala churna significantly improved urine parameters. Triphala churna treatment also improved plasma proteins, albumin, creatinine, and BUN levels. The oxidative stress was reduced in the kidney with the treatment of Triphala churna. Histopathological studies revealed that Triphala churna reduced kidney damage. Immunohistochemistry, ELISA, and western blotting study revealed that treatment with Triphala decreased the expression of TGF-beta in kidney tissues. Conclusion: From the results, it can be concluded that Triphala churna has a significant nephroprotective effect because of its capability of inhibiting oxidative stress and TGF-beta in diabetes.
引用
收藏
页码:681 / 691
页数:11
相关论文
共 50 条
  • [31] Combination of Ginsenoside Rg1 and Astragaloside IV reduces oxidative stress and inhibits TGF-β1/Smads signaling cascade on renal fibrosis in rats with diabetic nephropathy
    Du, Na
    Xu, Zhiping
    Gao, Mingyue
    Liu, Peng
    Sun, Bo
    Cao, Xia
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2018, 12 : 3517 - 3524
  • [32] Salidroside from Rhodiola rosea L. attenuates diabetic nephropathy in STZ induced diabetic rats via anti-oxidative stress, anti-inflammation, and inhibiting TGF-β1/Smad pathway
    Qi, Shan Shan
    Shao, Meng Li
    Ze, Sun
    Zheng, Hong Xing
    JOURNAL OF FUNCTIONAL FOODS, 2021, 77
  • [33] Huangkui capsule in combination with metformin ameliorates diabetic nephropathy via the Klotho/TGF-β1/p38MAPK signaling pathway
    Gu, Li-Yuan
    Yun-Sun
    Tang, Hai-Tao
    Xu, Zheng-Xin
    JOURNAL OF ETHNOPHARMACOLOGY, 2021, 281
  • [34] Apigenin ameliorates streptozotocin-induced diabetic nephropathy in rats via MAPK-NF-κB-TNF-α and TGF-β1-MAPK-fibronectin pathways
    Malik, Salma
    Suchal, Kapil
    Khan, Sana Irfan
    Bhatia, Jagriti
    Kishore, Kamal
    Dinda, Amit Kumar
    Arya, Dharamvir Singh
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2017, 313 (02) : F414 - F422
  • [35] Sugar, Sex, and TGF-β in Diabetic Nephropathy
    Diamond-Stanic, Maggie K.
    You, Young H.
    Sharma, Kumar
    SEMINARS IN NEPHROLOGY, 2012, 32 (03) : 261 - 268
  • [36] Potential role of TGF-β in diabetic nephropathy
    Hoffman, BB
    Sharma, K
    Ziyadeh, FN
    MINERAL AND ELECTROLYTE METABOLISM, 1998, 24 (2-3) : 190 - 196
  • [37] Dapagliflozin and metformin in combination ameliorates diabetic nephropathy by suppressing oxidative stress, inflammation, and apoptosis and activating autophagy in diabetic rats
    Jaikumkao, Krit
    Thongnak, Laongdao
    Htun, Khin Thandar
    Pengrattanachot, Nattavadee
    Phengpol, Nichakorn
    Sutthasupha, Prempree
    Promsan, Sasivimon
    Montha, Napatsorn
    Sriburee, Sompong
    Kothan, Suchart
    Lungkaphin, Anusorn
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2024, 1870 (01):
  • [38] Evodiamine ameliorates liver fibrosis in rats via TGF-β1/Smad signaling pathway
    Yang, Dongmei
    Li, Li
    Qian, Shanjun
    Liu, Lixin
    JOURNAL OF NATURAL MEDICINES, 2018, 72 (01) : 145 - 154
  • [39] Evodiamine ameliorates liver fibrosis in rats via TGF-β1/Smad signaling pathway
    Dongmei Yang
    Li Li
    Shanjun Qian
    Lixin Liu
    Journal of Natural Medicines, 2018, 72 : 145 - 154
  • [40] Resveratrol ameliorates early diabetic nephropathy associated with suppression of augmented TGF-β/smad and ERK1/2 signaling in streptozotocin-induced diabetic rats
    Chen, Kuan-Hsing
    Hung, Cheng-Chieh
    Hsu, Hsiang-Hao
    Jing, Yu-Hong
    Yang, Chih-Wei
    Chen, Jan-Kan
    CHEMICO-BIOLOGICAL INTERACTIONS, 2011, 190 (01) : 45 - 53